The following inventory compiles the modalities, sections, nuclei/cells counts, and tumor-site compartments reported for the GBM-Space atlas and companion datasets, as described in the spatial vascular/BTB remodeling analysis .
| Modality / Dataset | Sections / Samples | Counts (nuclei, cells, or patients) | Tumor Sites / Compartments | Role |
|---|---|---|---|---|
| Spatial transcriptomics (GBM-Space primary) | 38 sections | 6 donors | LE, IT, CT compartments | Primary discovery |
| Spatial transcriptomics (complete triads, MIN50) | 5 sections | 4 donors | LE / IT / CT complete triads | Donor-level analysis |
| Spatial transcriptomics (IT-CT pairs) | 17 sections | 4 donors | IT and CT | Pairwise regional contrast |
| Single-nucleus RNA-seq (GBM-Space) | 12 tumors | 1,025,329 nuclei; 2,241 endothelial (1,363 canonical, 878 remodeled) | Tumor-wide; endothelial state layer | Endothelial state comparison |
| Xenium spatial localization | Technical localization panels | 106,778 cells | PLVAP/CAV1/MFSD2A sites (no THSD1/FLT4/MFSD2A panel) | Localization support |
| GSE162631 (bulk regional) | 4 paired patients | 4 patients (core + peripheral pairs) | Tumor core vs peripheral tissue | External replication |
| Ivy GAP / GSE107559 ASTR122 | 10 tumors (8 complete) | 8 complete LE/IT/CT tumors | LE, IT, CT anatomical regions | Anatomical replication |
| GSE131928 (single-cell malignant states) | 20 adult tumors (16 for trajectories) | 4,873 malignant cells | OPC/NPC/AC/MES malignant states | Malignant-state architecture |
Notes on tumor sites: The spatial cohort partitions sections across three histopathology-annotated compartments β leading edge (LE), infiltrative tumor (IT), and cellular tumor (CT) β with donor-level complete-triad analysis restricted to 4 donors having all three compartments . External validation sites include paired core/peripheral regions (GSE162631), anatomical LE/IT/CT (Ivy GAP), and malignant-state (OPC/NPC/AC/MES) classifications (GSE131928) .
Data access: Processed GBM-Space data via https://www.gbmspace.org/; Xenium S2/S6 files at Zenodo (DOI: 10.5281/zenodo.17622242); GEO accessions GSE162631, GSE107559, GSE131928 .
Limitations: Cross-sectional design; modest donor numbers (6 spatial donors, 12 snRNA tumors); Xenium panel did not measure THSD1/FLT4/MFSD2A; no direct BTB permeability assay. Counts are as reported by the authors and not independently verified.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.